KENDALL CAPITAL MANAGEMENT – AbbVie Inc. Transaction History
KENDALL CAPITAL MANAGEMENT portfolio value:
$4.30M
portfolio value
KENDALL CAPITAL MANAGEMENT quarter portfolio value change:
-12.37%
quarter
AbbVie Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -1.14% | -370 shares | -665K | $134.21 | 32.10K |
Q2 2022 | share | Decrease | -2.54% | -845 shares | -428K | $153.16 | 32.47K |
Q1 2022 | share | Decrease | -5.17% | -1.81K shares | 644K | $162.11 | 33.32K |
Q4 2021 | share | Decrease | -2.22% | -796 shares | 882K | $135.93 | 35.13K |
Q3 2021 | share | Decrease | -2.52% | -930 shares | -276K | $106.6 | 35.93K |
Q2 2021 | share | Decrease | -1.69% | -635 shares | 94K | $110.09 | 36.86K |
Q1 2021 | share | Increase | +0.83% | 310 shares | 73K | $104.49 | 37.5K |
Q4 2020 | share | Decrease | -0.89% | -335 shares | 698K | $102.27 | 37.19K |
Q3 2020 | share | Increase | +2.37% | 870 shares | -312K | $82.47 | 37.52K |
Q2 2020 | share | Increase | +10.81% | 3.57K shares | 1.07M | $91.35 | 36.65K |
Q1 2020 | share | Decrease | -8.08% | -2.90K shares | -666K | $69.88 | 33.08K |
Q4 2019 | share | Increase | +2.92% | 1.02K shares | 539K | $80.14 | 35.98K |
Q3 2019 | share | Increase | +7.93% | 2.57K shares | 291K | $67.55 | 34.96K |
Q2 2019 | share | Increase | +2.79% | 878 shares | -184K | $63.9 | 32.39K |
Q1 2019 | share | Increase | +4.46% | 1.34K shares | -241K | $69.89 | 31.51K |
Q4 2018 | share | Decrease | -1.58% | -483 shares | -118K | $78.96 | 30.17K |
Q3 2018 | share | Increase | +6.84% | 1.96K shares | 241K | $80.16 | 30.65K |
Q2 2018 | share | Increase | +3.48% | 965 shares | 34K | $77.74 | 28.69K |
Q1 2018 | share | Decrease | -0.31% | -85 shares | -66K | $78.6 | 27.72K |
Q4 2017 | share | Increase | 0.00% | 27.81K shares | 2.69M | $79.74 | 27.81K |